NHLRC2
-
Official Full Name
NHL repeat containing 2 -
Synonyms
NHLRC2;NHL repeat containing 2;NHL repeat-containing protein 2;DKFZp779F115;FLJ20147;FLJ25621;FLJ33312;MGC45492;1200003G01Rik;Novel NHL repeat domain containing protein;OTTHUMP00000020518
| Cat.# | Product name | Source (Host) | Species | Tag | Protein Length | Price |
|---|---|---|---|---|---|---|
| NHLRC2-1643C | Recombinant Chicken NHLRC2 | Mammalian Cells | Chicken | His |
|
|
| NHLRC2-1193HCL | Recombinant Human NHLRC2 cell lysate | Human | Non |
|
||
| Nhlrc2-4414M | Recombinant Mouse Nhlrc2 Protein, Myc/DDK-tagged | HEK293 | Mouse | Myc&DDK |
|
Involved Pathway
NHLRC2 involved in several pathways and played different roles in them. We selected most pathways NHLRC2 participated on our site, such as , which may be useful for your reference. Also, other proteins which involved in the same pathway with NHLRC2 were listed below. Creative BioMart supplied nearly all the proteins listed, you can search them on our site.
| Pathway Name | Pathway Related Protein |
|---|
Protein Function
NHLRC2 has several biochemical functions, for example, protein binding. Some of the functions are cooperated with other proteins, some of the functions could acted by NHLRC2 itself. We selected most functions NHLRC2 had, and list some proteins which have the same functions with NHLRC2. You can find most of the proteins on our site.
| Function | Related Protein |
|---|---|
| protein binding | IREB2,TRIM42,F2R,FBXO33,ASAP3,FASN,CLK2,CLOCKB,PRKG1,PRPF31 |
Interacting Protein
NHLRC2 has direct interactions with proteins and molecules. Those interactions were detected by several methods such as yeast two hybrid, co-IP, pull-down and so on. We selected proteins and molecules interacted with NHLRC2 here. Most of them are supplied by our site. Hope this information will be useful for your research of NHLRC2.
CEP76
Resources
Related Services
Related Products
References
- Brackmann, FA; Kiefer, A; et al. Rapidly Progressive Phenotype of Lafora Disease Associated With a Novel NHLRC1 Mutation. PEDIATRIC NEUROLOGY 44:475-477(2011).
- Oki, Y; Ogura, M; et al. Phase II study of a salvage regimen using cyclophosphamide, high-dose cytarabine, dexamethasone, etoposide, and rituximab in patients with relapsed or refractory B-cell non-Hodgkin's lymphoma. CANCER SCIENCE 99:179-184(2008).
